WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors

NCT04334863 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Brain Tumor
Medulloblastoma
Brain Metastases

Interventions

DRUG: WP1066

Sponsor

Emory University

Collaborators

[object Object]
[object Object]